Medjool Date Consumption Trial to Assess Spontaneous Labor Incidence and Reduce Induction Need

Labor induction is a common obstetric intervention, often necessitated by various maternal or fetal indications. Current standard-of-care methods, such as cervical Foley catheters, misoprostol, and intravenous oxytocin, are effective but can be associated with longer labor durations and potential complications. There is growing interest in non-pharmacological interventions to promote spontaneous labor and reduce the need for induction. Medjool dates have been anecdotally suggested to facilitate cervical ripening and labor progression, potentially offering a natural alternative to improve labor outcomes.

This proposed randomized controlled trial will enroll pregnant patients from 34 weeks gestation through the day after delivery. Participants will be randomized to either consume Medjool dates or a control arm. The intervention group will consume Medjool dates daily from 34 weeks gestation until delivery. The primary endpoint will compare the incidence of spontaneous labor with the need for labor induction between the two groups. Secondary outcomes will include length of labor, need for oxytocin, dose of oxytocin, and quantitative blood loss at delivery. Dietary intake will be assessed to control for confounding factors and understand the impact on overall maternal diet quality.

As a proposed randomized controlled trial, this study has not yet generated specific findings or numerical results. However, the primary outcome will be the incidence of spontaneous labor versus the need for labor induction. Secondary outcomes will include the measurement of labor duration, the requirement for oxytocin augmentation, the specific oxytocin dose administered, and quantitative blood loss at delivery. The study also aims to explore the association between Medjool date consumption, perinatal hemoglobin levels, and overall maternal diet quality. The most critical intended finding is: > Medjool date consumption from 34 weeks gestation will increase the incidence of spontaneous labor and reduce the need for labor induction, potentially improving various labor and delivery outcomes.